Related articles

• Anlotinib reverses osimertinib resistance via inhibiting epithelial-to-mesenchymal transition and angiogenesis in non-small cell lung cancer
  DOI: 10.7555/JBR.38.20240045
• Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma
  2023, 37(3): 225-228. DOI: 10.7555/JBR.36.20220138
• A novel long non-coding RNA NFIA-AS1 is down-regulated in gastric cancer and inhibits proliferation of gastric cancer cells
  2019, 33(6): 371-381. DOI: 10.7555/JBR.33.20190015
• Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer
  2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
• PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancer
  2014, 28(6): 462-467. DOI: 10.7555/JBR.27.20130084
• Partial removal of the pulmonary artery in video-assisted thoracic surgery for non-small cell lung cancer
  2013, 27(4): 310-317. DOI: 10.7555/JBR.27.20120066
• Prognostic assessment of apoptotic gene polymorphisms in non-small cell lung cancer in Chinese
  2013, 27(3): 231-238. DOI: 10.7555/JBR.27.20130014
• Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
  2013, 27(3): 220-230. DOI: 10.7555/JBR.27.20130004
• Expression of cytochrome P450 2A13 in human non-small cell lung cancer and its clinical significance
  2013, 27(3): 202-207. DOI: 10.7555/JBR.27.20120019
• Weekly intravenous nanoparticle albumin-bound paclitaxel for elderly patients with stage IV non-small-cell lung cancer: a series of 20 cases
  2012, 26(3): 159-164. DOI: 10.7555/JBR.26.20110106